The AI-Biotech Convergence: How Machine Learning Is Revolutionizing Drug Discovery and Genomics in 2026
Biotechnology and artificial intelligence are converging at unprecedented speed in 2026. From AlphaFold’s 200+ million protein structures to AI-driven drug discovery companies reshaping pharma, this convergence is fundamentally transforming how we develop medicines and understand human genetics.








